ArticleCurrent protocols2026
From Struggling (With) Screening Tests to Mouse Models of Depression-Relevant Neurobehavioral States.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Struggling (With) Screening Tests to Mouse Models of Depression-Relevant Neurobehavioral States.Current protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
A major, serendipitous psychiatric discovery is monoamine-transporter reuptake inhibition as an antidepressant mechanism of action. Chronic treatment with such antidepressants is efficacious, with onset requiring 1-2 weeks, in many but by no means all patients with major depressive or another stress-related neuropsychiatric disorder. The forced swim test (FST) in rats and mice involves the acute, moderate stressor of placement in a container of water: at test onset, the predominant reaction is swimming, interpreted cautiously as active "struggling"; over minutes, this is replaced by floating, described objectively as immobility. Acute administration of monoamine transporter inhibitors immediately prolongs "struggling." Although this readout is of behavioral pharmacological interest, the FST has no (back-)translational relevance to the neurobiological and neuropsychological symptoms/states of stress-related psychiatric disorders. The persistent adoption of the FST to measure "depression-like state," based on interpretation of immobility as "despair," "helplessness," or "passive coping," is a major weakness in applied behavioral neuroscience. Rodents do have a concept of learned uncontrollability, such that tests showing this depict an adaptive, not a "depression-like," state. Recent psychiatry-neuroscience initiatives, such as the Research Domain Criteria framework, increase the accessibility of specific, transdiagnostic symptoms/states to behavioral neuroscience methods, thereby facilitating the establishment of animal models. Such animal models must incorporate clinically valid (1) etiological factors, such as prolonged psychosocial stress, and (2) neurobehavioral readouts with face and construct validity for specific symptoms/states. Increased reactivity to an acute threat, measured as increased Pavlovian aversion learning-memory (PALM), is a neurobehavioral state common in major depression and other disorders. Mice that have undergone chronic social stress exhibit generalized excessive PALM. Therefore, although stating that the FST measures "depression-like state" is erroneous, mouse models of specific symptoms/states can be achieved by back-translating etiology and neurobehavioral readouts. Though complex and moderately severe, such models have the potential to provide much-needed benefits in terms of preclinical neuropharmacological target discovery and validation. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.